Timothy B. Hallett

22.8k total citations · 3 hit papers
197 papers, 9.7k citations indexed

About

Timothy B. Hallett is a scholar working on Infectious Diseases, Epidemiology and General Health Professions. According to data from OpenAlex, Timothy B. Hallett has authored 197 papers receiving a total of 9.7k indexed citations (citations by other indexed papers that have themselves been cited), including 152 papers in Infectious Diseases, 100 papers in Epidemiology and 83 papers in General Health Professions. Recurrent topics in Timothy B. Hallett's work include HIV/AIDS Research and Interventions (143 papers), HIV, Drug Use, Sexual Risk (77 papers) and Adolescent Sexual and Reproductive Health (75 papers). Timothy B. Hallett is often cited by papers focused on HIV/AIDS Research and Interventions (143 papers), HIV, Drug Use, Sexual Risk (77 papers) and Adolescent Sexual and Reproductive Health (75 papers). Timothy B. Hallett collaborates with scholars based in United Kingdom, United States and Zimbabwe. Timothy B. Hallett's co-authors include Simon Gregson, Geoff P. Garnett, Geoffrey P. Garnett, Jeffrey W. Eaton, Shevanthi Nayagam, Mark Thursz, Mikaëla Smit, Íde Cremin, Constance Nyamukapa and Jennifer Smith and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Timothy B. Hallett

191 papers receiving 9.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Future challenges for clinical care of an ageing population infected with HIV: a modelling study

2015 619 citations Mikaëla Smit, Kees Brinkman et al. profile →
HIV and risk environment for injecting drug users: the past, present, and future

2010 428 citations Timothy B. Hallett et al. The Lancet profile →
Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe

2020 307 citations Jeffrey W. Eaton, Timothy B. Hallett et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Timothy B. Hallett United Kingdom	54	6.3k	4.7k	2.9k	1.5k	1.4k	197	9.7k
Kevin M. De Cock United States	62	10.1k 1.6×	7.3k 1.5×	2.2k 0.8×	1.2k 0.8×	2.5k 1.8×	250	13.5k
George R. Seage United States	57	7.1k 1.1×	4.3k 0.9×	2.5k 0.9×	1.2k 0.8×	2.7k 1.9×	213	10.4k
Francisco Inácio Bastos Brazil	47	3.9k 0.6×	3.5k 0.7×	2.3k 0.8×	1.4k 0.9×	848 0.6×	311	7.7k
Kenneth A. Freedberg United States	56	8.1k 1.3×	5.1k 1.1×	2.1k 0.7×	593 0.4×	3.3k 2.3×	271	10.6k
Heiner Grosskurth United Kingdom	51	5.3k 0.8×	3.2k 0.7×	3.9k 1.4×	1.5k 1.0×	1.2k 0.9×	231	9.5k
Jonathan Mermin United States	71	11.1k 1.8×	7.7k 1.6×	4.1k 1.4×	2.0k 1.3×	3.0k 2.2×	203	15.4k
Sten H. Vermund United States	63	9.7k 1.5×	9.1k 1.9×	4.2k 1.5×	1.8k 1.2×	2.9k 2.1×	587	18.2k
Quarraisha Abdool Karim South Africa	48	7.2k 1.1×	4.1k 0.9×	3.7k 1.3×	1.3k 0.8×	2.7k 1.9×	246	11.2k
Lawrence H. Moulton United States	64	5.8k 0.9×	5.9k 1.2×	2.5k 0.9×	863 0.6×	1.0k 0.7×	258	16.4k
Janet Seeley United Kingdom	49	5.2k 0.8×	3.1k 0.7×	4.4k 1.5×	2.5k 1.6×	739 0.5×	602	11.0k

Countries citing papers authored by Timothy B. Hallett

Since Specialization

Citations

This map shows the geographic impact of Timothy B. Hallett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothy B. Hallett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothy B. Hallett more than expected).

Fields of papers citing papers by Timothy B. Hallett

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timothy B. Hallett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothy B. Hallett. The network helps show where Timothy B. Hallett may publish in the future.

Co-authorship network of co-authors of Timothy B. Hallett

This figure shows the co-authorship network connecting the top 25 collaborators of Timothy B. Hallett. A scholar is included among the top collaborators of Timothy B. Hallett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Timothy B. Hallett. Timothy B. Hallett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hallett, Timothy B., Nicolas A. Menzies, Stephen Resch, et al.. (2025). The case for optimal investment in combating HIV, tuberculosis, and malaria: a global modelling study. The Lancet. 406(10500). 261–270.

Villiers, Margaret J. de, Ethel‐Michele de Villiers, Shevanthi Nayagam, & Timothy B. Hallett. (2024). Direct and indirect effects of hepatitis B vaccination in four low- and middle-income countries. Epidemics. 49. 100798–100798. 1 indexed citations

Guzauskas, Gregory F. & Timothy B. Hallett. (2023). The long‐term impact and value of curative therapy for HIV: a modelling analysis. Journal of the International AIDS Society. 26(9). e26170–e26170. 5 indexed citations

Pickles, Michael, Simon Gregson, Tawanda Dadirai, et al.. (2023). Strengthening the HIV prevention cascade to maximise epidemiological impact in eastern Zimbabwe: a modelling study. The Lancet Global Health. 11(7). e1105–e1113. 5 indexed citations

Schmit, Nora, Shevanthi Nayagam, Maud Lemoine, et al.. (2023). Cost-effectiveness of different monitoring strategies in a screening and treatment programme for hepatitis B in The Gambia. Journal of Global Health. 13. 4004–4004. 2 indexed citations

Denkinger, Claudia M., et al.. (2020). The potential impact of urine-LAM diagnostics on tuberculosis incidence and mortality: A modelling analysis. PLoS Medicine. 17(12). e1003466–e1003466. 13 indexed citations

Case, Kelsey K., Gabriela B. Gomez, & Timothy B. Hallett. (2019). The impact, cost and cost‐effectiveness of oral pre‐exposure prophylaxis in sub‐Saharan Africa: a scoping review of modelling contributions and way forward. Journal of the International AIDS Society. 22(9). e25390–e25390. 26 indexed citations

Hallett, Timothy B., et al.. (2019). The potential impact of a “curative intervention” for HIV: a modelling study. Global Health Research and Policy. 4(1). 2–2. 12 indexed citations

Eaton, Jeffrey W., et al.. (2018). Optimal timing of HIV home‐based counselling and testing rounds in Western Kenya. Journal of the International AIDS Society. 21(6). e25142–e25142. 3 indexed citations

10.

Smit, Mikaëla, Rachel Cassidy, Alessandro Cozzi‐Lepri, et al.. (2017). Projections of non-communicable disease and health care costs among HIV-positive persons in Italy and the U.S.A.: A modelling study. PLoS ONE. 12(10). e0186638–e0186638. 91 indexed citations

11.

Hargreaves, James, Sinéad Delany‐Moretlwe, Timothy B. Hallett, et al.. (2016). The HIV prevention cascade: integrating theories of epidemiological, behavioural, and social science into programme design and monitoring. The Lancet HIV. 3(7). e318–e322. 107 indexed citations

12.

Eaton, Jeffrey W. & Timothy B. Hallett. (2014). Why the proportion of transmission during early-stage HIV infection does not predict the long-term impact of treatment on HIV incidence. Proceedings of the National Academy of Sciences. 111(45). 16202–16207. 34 indexed citations

13.

Dimitrov, Dobromir, Marie‐Claude Boily, & Timothy B. Hallett. (2014). How Much Do We Know about Drug Resistance Due to PrEP Use? Analysis of Experts' Opinion and Its Influence on the Projected Public Health Impact. AIDS Research and Human Retroviruses. 30(S1). A161–A161. 3 indexed citations

14.

Smit, Mikaëla, Colette Smit, Suzanne E. Geerlings, et al.. (2013). Changes in First-Line cART Regimens and Short-Term Clinical Outcome between 1996 and 2010 in The Netherlands. PLoS ONE. 8(9). e76071–e76071. 11 indexed citations

15.

Hallett, Timothy B. & Jeffrey W. Eaton. (2013). A Side Door Into Care Cascade for HIV-Infected Patients?. JAIDS Journal of Acquired Immune Deficiency Syndromes. 63(Supplement 2). S228–S232. 87 indexed citations

16.

Vijver, David van de, Brooke E Nichols, Valentina Cambiano, et al.. (2012). Pre-exposure prophylaxis (PrEP) will have a limited impact on the prevalence of HIV-1 drug resistance in sub-Saharan Africa: comparison of mathematical models. Journal of the International AIDS Society. 15. 140–141. 1 indexed citations

17.

Hallett, Timothy B., Jared M. Baeten, Renee Heffron, et al.. (2011). Optimal Uses of Antiretrovirals for Prevention in HIV-1 Serodiscordant Heterosexual Couples in South Africa: A Modelling Study. PLoS Medicine. 8(11). e1001123–e1001123. 122 indexed citations

18.

Bärnighausen, Till, Frank Tanser, Timothy B. Hallett, & Marie‐Louise Newell. (2010). Short Communication: Prioritizing Communities for HIV Prevention in sub-Saharan Africa. AIDS Research and Human Retroviruses. 26(4). 401–405. 9 indexed citations

19.

Hallett, Timothy B., Ramzi Alsallaq, Jared M. Baeten, et al.. (2010). Will circumcision provide even more protection from HIV to women and men? New estimates of the population impact of circumcision interventions. Sexually Transmitted Infections. 87(2). 88–93. 72 indexed citations

20.

Hallett, Timothy B., Simon Gregson, Sabada Dube, & Geoff P. Garnett. (2008). The Impact of Monitoring HIV Patients Prior to Treatment in Resource-Poor Settings: Insights from Mathematical Modelling. PLoS Medicine. 5(3). e53–e53. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact